Categories Earnings Calls, Other Industries

Eli Lilly & Co (LLY) Q4 2020 Earnings Call

Eli Lilly & Co  (NYSE: LLY) Q4 2020 earnings call dated Jan. 29, 2021

Corporate Participants:

Kevin Hern — Vice President of Investor Relations

David A. Ricks — Chairman and Chief Executive Officer

Joshua L. Smiley — Senior Vice President and Chief Financial Officer

Daniel M. Skovronsky — Senior Vice President and Chief Scientific Officer

Anne E. White — Senior Vice President and President of Lilly Oncology

Analysts:

Geoff Meacham — Bank of America — Analyst

Tim Anderson — Wolfe Research — Analyst

Umer Raffat — Evercore — Analyst

Steve Scala — Cowen and Company — Analyst

David Risinger — Morgan Stanley — Analyst

Daniel Ziment — Goldman Sachs — Analyst

Chris Schott — J.P. Morgan — Analyst

Seamus Fernandez — Guggenheim — Analyst

Andrew Baum — Citigroup — Analyst

Gregg Gilbert — Truist Securities — Analyst

Ronny Gal — Bernstein — Analyst

Vamil Divan — Mizuho Securities — Analyst

Carter Gould — Barclays — Analyst

Kerry Holford — Berenberg — Analyst

_________
To read the full earnings call transcript, click here

Most Popular

Nvidia (NVDA) likely to report strong results once again, fueled by AI boom

Nvidia Corporation (NASDAQ: NVDA) has been at the forefront of the artificial intelligence revolution, developing high-tech AI chips that provide the computational power and efficiency required for training and deploying

What to expect when Lowe’s Companies (LOW) reports Q4 2024 earnings

Shares of Lowe’s Companies, Inc. (NYSE: LOW) stayed red on Tuesday. The stock has dropped 8% over the past three months. The home improvement retailer is slated to report its

MDT Earnings: Medtronic reports higher Q3 2025 revenue and adj. profit

Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported an increase in revenues and adjusted profit for the third quarter of 2025. Third-quarter earnings, excluding special items, rose 7%

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close